INVA - Innoviva, Inc.

QQQ $ 428.63 $ 0.33 (0.08 %)

DIA $ 385.03 $ 2.65 (0.69 %)

SPY $ 505.65 $ 5.93 (1.19 %)

TLT $ 89.02 $ 0.03 (0.03 %)

GLD $ 214.38 $ 0.00 (0 %)

Previous Close

$ 15.17

Open

$ 15.08

Bid

$ 15.16 x 200

Ask

$ 15.17 x 200

Day's Range

$ 14.98 - $ 15.32

52 Week Range

$ 11.37 - $ 16.87

Volume

1,492,750

Average Volume

Market Cap

1.32B

Beta (5Y Monthly)

$ 0.66

PE Ratio (TTM)

$ 7.33

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-29-2024	12-31-2023	10-K
2	11-01-2023	09-30-2023	10-Q
3	08-02-2023	06-30-2023	10-Q
4	05-09-2023	03-31-2023	10-Q
5	02-28-2023	12-31-2022	10-K
6	11-09-2022	09-30-2022	10-Q
7	07-27-2022	06-30-2022	10-Q
8	05-05-2022	03-31-2022	10-Q
9	02-28-2022	12-31-2021	10-K
10	10-27-2021	09-30-2021	10-Q
11	07-29-2021	06-30-2021	10-Q
12	04-28-2021	03-31-2021	10-Q
13	02-25-2021	12-31-2020	10-K
14	10-28-2020	09-30-2020	10-Q
15	07-29-2020	06-30-2020	10-Q
16	04-29-2020	03-31-2020	10-Q
17	02-19-2020	12-31-2019	10-K
18	10-30-2019	09-30-2019	10-Q
19	07-24-2019	06-30-2019	10-Q
20	05-01-2019	03-31-2019	10-Q
21	02-19-2019	12-31-2018	10-K
22	10-31-2018	09-30-2018	10-Q
23	07-26-2018	06-30-2018	10-Q
24	05-04-2018	03-31-2018	10-Q
25	02-23-2018	12-31-2017	10-K
26	11-03-2017	09-30-2017	10-Q
27	08-08-2017	06-30-2017	10-Q
28	05-05-2017	03-31-2017	10-Q
29	02-28-2017	12-31-2016	10-K
30	11-03-2016	09-30-2016	10-Q
31	08-04-2016	06-30-2016	10-Q
32	05-05-2016	03-31-2016	10-Q
33	02-24-2016	12-31-2015	10-K
34	11-05-2015	09-30-2015	10-Q
35	08-06-2015	06-30-2015	10-Q
36	05-08-2015	03-31-2015	10-Q
37	02-27-2015	12-31-2014	10-K
38	11-04-2014	09-30-2014	10-Q
39	08-07-2014	06-30-2014	10-Q
40	05-07-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Innoviva Specialty Announced That Positive...
04/24/2024 11:12:41

Armata Pharmaceuticals Enters Secured Cred...
03/04/2024 21:03:01

The gross proceeds to be received by the Company at closing are $35 million before deducting transaction-related expenses. Proc...

5 Value Stocks In The Healthcare Sector
03/04/2024 14:44:45

Innoviva Q4 EPS $0.76 Beats $0.23 Estimate...
02/29/2024 21:29:29

Innoviva (NASDAQ:INVA) reported quarterly earnings of $0.76 per share which beat the analyst consensus estimate of $0.23 by 230...

Innoviva Q3 EPS $0.98, Sales $67.26M Miss ...
11/01/2023 21:39:06

Innoviva (NASDAQ:INVA) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $0.27 by 262...

Innoviva Q3 EPS $0.98 May Not Compare To $...
11/01/2023 21:38:51

Innoviva (NASDAQ:INVA) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $0.27 by 262...

The Global Antibiotic Research & Developme...
11/01/2023 21:37:46

A Phase 3 study of oral zoliflodacin met the primary endpoint when compared against the combination of injectable ceftriaxone a...

A Look Into Healthcare Sector Value Stocks
10/02/2023 14:43:55

XACDURO, The First And Only Antibiotic Dev...
09/18/2023 12:01:21

XACDURO is a new FDA-approved treatment used to fight against HABP/VABP infections caused by isolates of Acinetobacter baumanni...

CORRECTION: Innoviva Q2 EPS $0.02 Misses $...
08/02/2023 23:21:32

Innoviva (NASDAQ:INVA) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.26 by 9...

Innoviva Q2 EPS $0.02 Misses $0.26 Estimat...
08/02/2023 21:16:47

Innoviva (NASDAQ: INVA) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.26 by ...

overview-of-value-stocks-in-the-healthcare-sector

Overview Of Value Stocks In The Healthcare...
07/31/2023 14:44:59

Armata Pharmaceuticals Announces New Finan...
07/11/2023 12:21:45

Signs new $25 million credit agreement and extension of existing secured convertible credit agreement Appoints world‐renowned ...

astrazeneca-spin-off-entasis-secures-fda-approval-for-first-pathogen-targeted-therapy-addressing-acinetobacter

AstraZeneca-Spin Off Entasis Secures FDA A...
05/24/2023 15:49:54

Over $125M Bet On Occidental Petroleum? Ch...
05/16/2023 13:08:52

Although US stocks closed higher on Monday, there were a few notable insider trades.

A Look Into Healthcare Sector Value Stocks
05/15/2023 14:43:07

EF Hutton Reiterates Buy on Innoviva, Main...
05/10/2023 11:57:58

EF Hutton analyst Constantine Davides reiterates Innoviva (NASDAQ:INVA) with a Buy and maintains $22.5 price target.

CORRECTION: Innoviva Q1 EPS $0.42 Beats $0...
05/10/2023 04:29:19

Innoviva (NASDAQ:INVA) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.23 by 82....

Innoviva Q1 EPS $0.42 Beats $0.23 Estimate...
05/09/2023 21:02:17

Innoviva (NASDAQ: INVA) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.23 by 82...

5 Value Stocks In The Healthcare Sector
05/08/2023 14:43:06